Join
Live feed
·
INSIDERFilingvia Quantisnow
Adaptive Biotechnologies Corporation logo

Chief Commercial Ofc Imm Med Benzeno Sharon exercised 510,470 shares at a strike of $8.75 and sold $10,144,026 worth of shares (606,402 units at $16.73), decreasing direct ownership by 24% to 296,791 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADPT (Adaptive Biotechnologies Corporation) and more on Quantisnow.